Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Description

The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).

Conditions

Cancer Patients

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this 1 year study is to see if the ICCAN program is working, and to compare the ICCAN program to the standard hospital services provided in New York City hospitals, like meeting with a Social Worker or a Patient Navigator (a person who provides personal hospital guidance).

A Randomized Controlled Trial of the Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Impact of ICCAN on Cancer Treatment Completion and Quality of Life

Condition
Cancer Patients
Intervention / Treatment

-

Contacts and Locations

Basking Ridge

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States, 07920

Middletown

Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States, 07748

Montvale

Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States, 07645

Bronx

Lincoln Hospital and Mental Health Center, Bronx, New York, United States,

Brooklyn

Lutheran Medical Center, Brooklyn, New York, United States, 11220

Commack

Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack, New York, United States, 11725

Harrison

Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States, 10604

New York

City College of New York (Data Collection AND Data Analysis), New York, New York, United States, 10031

New York

Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York, New York, United States, 10035

New York

Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * fluent in English, Spanish, or Mandarin
  • * between the ages of 21-80 years old
  • * cancer patients currently receiving chemotherapy (started within the past month) and/or radiation therapy (started within the past week), or
  • * scheduled to begin chemotherapy and/or radiation therapy within the next 2 months (excluding surgery only patients)
  • * planning on remaining in the area for at least 1 year
  • * Has an MD or DO degree
  • * Is the treating physician providing care to a patient enrolled to the study
  • * Is 18 - 85 years of age
  • * Has unresectable locally advanced, locally recurrent unresectable, metastatic, or high risk/early stage TNBC or stage I-IV lung cancer
  • * Eligible for FDA approved immunotherapy in the NYC metropolitan area (per self-report or per MSK patient EMR records).
  • * Is treated in the NY metropolitan area
  • * Self-identifies as Black or Hispanic, and/or is low-SES (low SES will be defined as household income \< 200% of federal poverty level)
  • * Has English or Spanish proficiency
  • * Agrees to be audio-recorded
  • * Is 18 - 85 years of age
  • * Has stage II-III TNBC
  • * Treated at MSK Manhattan or OneMSK regional sites
  • * Self identifies as Black or Hispanic, and/or is low SES (low SES will be defined as household income \< 200% of federal poverty level)
  • * Has English or Spanish proficiency
  • * Agrees to be audio-recorded
  • * Staff member who serves as an Access Facilitator
  • * Agrees to be audio-recorded
  • * Presence of untreated psychiatric disturbance (i.e. acute psychiatric symptoms which require individual treatment) and/or cognitive impairment disorder (e.g., delirium or dementia) verified by medical record sufficient to preclude completion of the assessment measures, interview or informed consent
  • * Presence of untreated psychiatric disturbance (e.g., acute psychiatric symptoms which require individual treatment) and/or cognitive impairment disorder (e.g., delirium or dementia) sufficient to preclude completion of the assessment measures, interview or informed consent
  • * Participants or family members who are participating in MSK IHCD studies related to social determinants of health
  • * Presence of untreated psychiatric disturbance (e.g, acute psychiatric symptoms which require individual treatment) and/or cognitive impairment disorder (e.g., delirium or dementia) sufficient to preclude completion of the assessment measures, interview or informed consent
  • * Participants or family members who are participating in MSK IHCD studies related to social determinants of health

Ages Eligible for Study

21 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Memorial Sloan Kettering Cancer Center,

Francesca Gany, MD, MS, PRINCIPAL_INVESTIGATOR, Memorial Sloan Kettering Cancer Center

Study Record Dates

2025-11